Close Menu

NEW YORK (GenomeWeb) – Researchers at the Garvan Institute of Medical Research in Australia said last week that they can diagnose rare, monogenic diseases more than half the time using whole-genome sequencing.

According to Mark Cowley, who presented the work at the Biology of Genomes meeting at Cold Spring Harbor Laboratory last week, this diagnostic rate is much better that the 25 percent rate typically observed with whole-exome sequencing.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Los Angeles brought and settled a civil enforcement action against the makers of an at-home test for SARS-CoV-2, NPR reports. 

The Guardian reports that Cancer Research UK is cutting its research funding by £44 million.

Technology Review examines factors affecting SARS-CoV-2 testing turnaround times.

In PNAS this week: mapping of ancient human migrations in Europe, recurrent gene fusion in breast cancer, and more.

May
06
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.